Recommendations made by the PBAC – May 2023 Intracycle meeting

Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) in May 2023 relating to the listing of drugs on the Pharmaceutical Benefits Scheme (PBS).

• May 2023 – PBAC Outcomes (PDF 151KB) – (Word 62KB)
• May 2023 – Fluticasone propionate (Axotide Junior®; Flixotide Junior®) Outcome (PDF 93KB) – (Word 52KB)